BIB

Ultra Nasdaq Biotechnology

BIB seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology® Index.

How to Buy
Why BIB?
Target Magnified Returns

BIB is the only ETF that targets 2x the daily returns of the Biotechnology industry.

Efficient

BIB offers 2x exposure with less cash.

Convenience

Buy and sell leveraged exposure via a single ticker in a brokerage account.

This ProShares ETF seeks daily investment results that correspond, before fees and expenses, to 2x the daily performance of its underlying benchmark (the “Daily Target”).

While the Fund has a daily investment objective, you may hold Fund shares for longer than one day if you believe it is consistent with your goals and risk tolerance. For any holding period other than a day, your return may be higher or lower than the Daily Target. These differences may be significant. Smaller index gains/losses and higher index volatility contribute to returns worse than the Daily Target. Larger index gains/losses and lower index volatility contribute to returns better than the Daily Target.

The more extreme these factors are, the more they occur together, and the longer your holding period while these factors apply, the more your return will tend to deviate. Investors should consider periodically monitoring their geared fund investments in light of their goals and risk tolerance.

Performance

30 Day Daily Return

Chart is updated nightly to reflect the more recent of the previous day's market closing price or the closing price on the day the fund was last traded.

Total Return

Fund 1m 3m 6m YTD 1Y 3Y 5Y 10Y Since Inception Inception Date
BIB NAV -7.55% 2.21% 37.13% 2.21% 70.94% 15.59% 0.06% 7.43% 16.31% 04/07/2010
BIB Market Price -7.52% 2.18% 37.06% 2.18% 70.63% 15.62% 0.04% 7.44% 16.31% 04/07/2010

The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than the original cost. Shares are bought and sold at market price (not NAV) and are not individually redeemed from the fund. Market price returns are based upon the midpoint of the bid/ask spread at 4:00 p.m. ET (when NAV is normally determined for most funds) and do not represent the returns you would receive if you traded shares at other times. Your brokerage commissions will reduce returns. Current performance may be lower or higher than the performance quoted. For standardized returns and performance data current to the most recent month end, see above.

About the Fund

Snapshot
  • Ticker
    BIB
  • Intraday Ticker
    BIB.IV
  • CUSIP
    74347R214
  • Inception Date
    4/7/10
  • Net Assets
    $76,190,299
  • Gross Expense Ratio
    1.19%
  • Net Expense Ratio
    0.95%
  • NAV Calculation Time
    4:00 p.m. ET
  • Distributions
    Quarterly
  • Options Available
    Yes
Price
as of 4/27/2026
  • NAV
    $81.93
  • NAV Change
    $-0.76 down caret
  • Market Price
    $82.09
  • Market Price Change
    $-0.62 down caret
  • Trading Volume (M)
    7,697
  • View Premium / Discount
Snapshot
  • Ticker
    BIB
  • Intraday Ticker
    BIB.IV
  • CUSIP
    74347R214
  • Inception Date
    4/7/10
  • Net Assets
    $76,190,299
  • Gross Expense Ratio
    1.19%
  • Net Expense Ratio
    0.95%
  • NAV Calculation Time
    4:00 p.m. ET
  • Distributions
    Quarterly
  • Options Available
    Yes
Price
as of 4/27/2026
  • NAV
    $81.93
  • NAV Change
    $-0.76 down caret
  • Market Price
    $82.09
  • Market Price Change
    $-0.62 down caret
  • Trading Volume (M)
    7,697
  • View Premium / Discount

Expenses with Contractual Waiver through September 30, 2026. Without the fee waiver performance would likely be lower.

Exposures

Index as of 3/31/2026

Holdings

as of 4/27/2026

Exposure Weight Ticker Description Exposure Value
(Notional + GL)
Market Value Shares/Contracts SEDOL Number
4.82% AMGN AMGEN INC -- $3,670,882.38 10,791 2023607
4.72% GILD GILEAD SCIENCES INC -- $3,592,457.75 28,121 2369174
4.71% VRTX VERTEX PHARMACEUTICALS INC -- $3,590,838.29 8,429 2931034
4.13% REGN REGENERON PHARMACEUTICALS -- $3,146,747.88 4,227 2730190
2.18% ALNY ALNYLAM PHARMACEUTICALS INC -- $1,664,719.96 5,396 B00FWN1
1.57% INSM INSMED INC -- $1,192,952.54 8,773 2614487
1.42% BIIB BIOGEN INC -- $1,078,780.57 5,971 2455965
1.39% RVMD REVOLUTION MEDICINES INC -- $1,061,918.55 8,065 BL71K91
1.33% UTHR UNITED THERAPEUTICS CORP -- $1,010,943.17 1,783 2430412
1.19% ARGX ARGENX SE - ADR -- $905,219.70 1,155 BDVLM39
1.14% RPRX ROYALTY PHARMA PLC- CL A -- $865,697.40 17,436 BMVP7Y0
1.06% ROIV ROIVANT SCIENCES LTD -- $811,381.90 29,134 BMW4NZ9
1.05% ILMN ILLUMINA INC -- $799,908.48 6,224 2613990
1.03% MRNA MODERNA INC -- $782,755.10 16,073 BGSXTS3
1.02% INCY INCYTE CORP -- $775,482.93 8,102 2471950
0.92% SMMT SUMMIT THERAPEUTICS INC -- $698,107.20 31,560 BMTVQS7
0.91% VTRS VIATRIS INC -- $694,070.65 46,865 BMWS3X9
0.77% BBIO BRIDGEBIO PHARMA INC -- $588,037.32 7,891 BK1KWG8
0.75% -- ASCENDIS PHARMA A/S -- $567,783.30 2,505 --
0.69% NBIX NEUROCRINE BIOSCIENCES INC -- $523,171.44 4,086 2623911
0.66% JAZZ JAZZ PHARMACEUTICALS PLC -- $504,056.10 2,505 B4Q5ZN4
0.64% MEDP MEDPACE HOLDINGS INC -- $486,682.35 1,155 BDCBC61
0.64% MDGL MADRIGAL PHARMACEUTICALS INC -- $485,764.06 934 BD59BS7
0.64% IONS IONIS PHARMACEUTICALS INC -- $485,746.75 6,725 BDJ0LS6
0.62% BNTX BIONTECH SE-ADR -- $473,252.22 4,637 BK6H543
0.62% GH GUARDANT HEALTH INC -- $472,324.50 5,337 BFXC911
0.62% EXEL EXELIXIS INC -- $471,995.15 10,571 2576941
0.60% SNY SANOFI-ADR -- $457,164.00 9,960 2964557
0.55% BMRN BIOMARIN PHARMACEUTICAL INC -- $421,185.54 7,828 2437071
0.55% ARWR ARROWHEAD PHARMACEUTICALS IN -- $419,667.20 5,702 BYQBFJ8
0.51% AXSM AXSOME THERAPEUTICS INC -- $390,166.80 2,082 BYZR4X4
0.51% ONC BEONE MEDICINES LTD-ADR -- $388,868.90 1,301 BYYWPW6
0.49% PRAX PRAXIS PRECISION MEDICINES I -- $375,342.66 1,134 BQ721R4
0.49% TEM TEMPUS AI INC-CL A -- $372,447.60 7,070 BSLSJJ0
0.46% PCVX VAXCYTE INC -- $349,780.04 5,857 BKPVGH6
0.43% KRYS KRYSTAL BIOTECH INC -- $325,118.00 1,192 BD6JX35
0.41% NUVL NUVALENT INC-A -- $310,039.20 2,980 BMVBZD3
0.41% HALO HALOZYME THERAPEUTICS INC -- $309,809.96 4,804 2975098
0.41% CYTK CYTOKINETICS INC -- $308,862.40 5,014 BBBSBJ5
0.40% IBRX IMMUNITYBIO INC -- $305,079.21 41,849 BNSP0B8
0.38% KYMR KYMERA THERAPEUTICS INC -- $287,864.28 3,321 BMPRZV5
0.37% ABVX ABIVAX SA-ADR -- $279,638.10 2,499 BLC89B2
0.34% PTGX PROTAGONIST THERAPEUTICS INC -- $255,928.98 2,598 BDCBCD8
0.32% COGT COGENT BIOSCIENCES INC -- $241,885.84 6,608 BLR6XK8
0.32% ERAS ERASCA INC -- $241,347.45 12,603 BNLYBF3
0.31% IMVT IMMUNOVANT INC -- $237,173.94 8,287 BJRFSB7
0.31% RYTM RHYTHM PHARMACEUTICALS INC -- $236,856.00 2,780 BF2YWG4
0.31% PTCT PTC THERAPEUTICS INC -- $233,132.96 3,368 B17VCN9
0.30% SYRE SPYRE THERAPEUTICS INC -- $229,792.40 3,196 BQBBDY8
0.30% CGON CG ONCOLOGY INC -- $229,660.34 3,437 BRBCSP4
0.30% TERN TERNS PHARMACEUTICALS INC -- $229,220.55 4,329 BMDJ0C9
0.30% CAI CARIS LIFE SCIENCES INC -- $228,915.98 11,486 BT18HP9
0.30% ALKS ALKERMES PLC -- $228,824.32 6,784 B3P6D26
0.30% MIRM MIRUM PHARMACEUTICALS INC -- $227,130.88 2,456 BJDX8Y8
0.28% APLS APELLIS PHARMACEUTICALS INC -- $213,062.85 5,203 BYTQ6X1
0.26% CRSP CRISPR THERAPEUTICS AG -- $199,217.93 3,907 BDHF4K6
0.26% LGND LIGAND PHARMACEUTICALS -- $195,849.90 810 2501578
0.25% APGE APOGEE THERAPEUTICS INC -- $192,914.57 2,231 BM9HHL5
0.25% CNTA CENTESSA PHARMACEUTICALS-ADR -- $192,374.19 4,869 BLB0YQ9
0.25% SRRK SCHOLAR ROCK HOLDING CORP -- $192,288.66 4,154 BFZQ0L8
0.24% XENE XENON PHARMACEUTICALS INC -- $183,724.36 3,386 BRJ3GY4
0.23% INDV INDIVIOR PHARMACEUTICALS INC -- $174,569.28 5,088 BTZRLN8
0.22% CRNX CRINETICS PHARMACEUTICALS IN -- $164,598.44 4,262 BDD19F8
0.21% AMRX AMNEAL PHARMACEUTICALS INC -- $160,971.42 12,806 BFNF1D6
0.20% ACAD ACADIA PHARMACEUTICALS INC -- $154,695.10 6,937 2713317
0.20% TVTX TRAVERE THERAPEUTICS INC -- $153,241.55 3,755 BLFGJD5
0.20% TWST TWIST BIOSCIENCE CORP -- $152,256.00 2,496 BGKG6G7
0.20% ORKA ORUKA THERAPEUTICS INC -- $150,488.30 1,970 BKVF0J2
0.19% TNGX TANGO THERAPEUTICS INC -- $144,341.06 5,482 BP2P6L0
0.19% GPCR STRUCTURE THERAPEUTICS INC -- $143,832.09 3,173 BQS9486
0.19% -- NEWAMSTERDAM PHARMA CO NV -- $142,445.10 4,678 BP8JSP4
0.18% EWTX EDGEWISE THERAPEUTICS INC -- $133,774.24 4,366 BKY5JZ8
0.17% DNLI DENALI THERAPEUTICS INC -- $128,692.76 6,454 BD2B4V0
0.17% ALMS ALUMIS INC -- $127,363.50 5,146 BPLQG36
0.16% BEAM BEAM THERAPEUTICS INC -- $120,947.26 4,147 BK6L288
0.16% DYN DYNE THERAPEUTICS INC -- $120,868.00 6,700 BN15WD1
0.16% ARQT ARCUTIS BIOTHERAPEUTICS INC -- $118,130.48 5,044 BKX9VD3
0.15% SUPN SUPERNUS PHARMACEUTICALS INC -- $115,439.64 2,334 B72ZBG4
0.14% VCYT VERACYTE INC -- $109,572.45 3,237 BFTWZY0
0.14% KOD KODIAK SCIENCES INC -- $109,569.24 2,484 BFXC933
0.14% RLAY RELAY THERAPEUTICS INC -- $108,761.25 7,275 BN2R582
0.14% ELVN ENLIVEN THERAPEUTICS INC -- $108,523.30 2,417 BMFD115
0.14% VERA VERA THERAPEUTICS INC -- $108,261.12 2,904 BL55460
0.14% IRON DISC MEDICINE INC -- $106,992.90 1,554 BMGJZJ8
0.14% TXG 10X GENOMICS INC-CLASS A -- $106,676.64 4,788 BKS3RS7
0.14% ADMA ADMA BIOLOGICS INC -- $105,966.35 9,695 B9NSBM2
0.14% TARS TARSUS PHARMACEUTICALS INC -- $105,530.76 1,732 BMH5RL1
0.14% IDYA IDEAYA BIOSCIENCES INC -- $105,391.00 3,575 BK0VHF6
0.12% RARE ULTRAGENYX PHARMACEUTICAL IN -- $94,352.67 3,933 BJ62Z18
0.12% BCRX BIOCRYST PHARMACEUTICALS INC -- $90,869.00 10,210 2100362
0.12% SRPT SAREPTA THERAPEUTICS INC -- $89,500.68 4,266 B8DPDT7
0.12% ADPT ADAPTIVE BIOTECHNOLOGIES -- $89,054.07 6,267 BJ5FZ74
0.12% AUPH AURINIA PHARMACEUTICALS INC -- $88,594.44 5,412 BFWLC09
0.11% GRAL GRAIL INC -- $87,151.68 1,584 BSLSSX7
0.11% ZYME ZYMEWORKS INC -- $87,050.88 3,048 BPCQZY9
0.11% MLYS MINERALYS THERAPEUTICS INC -- $86,961.78 3,222 BP9N0G0
0.11% DFTX DEFINIUM THERAPEUTICS INC -- $85,136.84 4,058 BV2DHY6
0.11% OCUL OCULAR THERAPEUTIX INC -- $84,356.72 8,861 BNZB1X8
0.11% KNSA KINIKSA PHARMACEUTICALS INTE -- $81,550.70 1,870 BRXB0C0
0.11% LEGN LEGEND BIOTECH CORP-ADR -- $81,237.75 3,435 BMX9K07
0.11% TYRA TYRA BIOSCIENCES INC -- $80,190.24 2,172 BMVNDH9
0.10% STOK STOKE THERAPEUTICS INC -- $78,342.04 2,324 BJQ05Z6
0.10% INBX INHIBRX BIOSCIENCES INC -- $77,686.95 591 BNSP8K3
0.10% VCEL VERICEL CORP -- $76,313.64 2,067 BSBMN89
0.10% AMLX AMYLYX PHARMACEUTICALS INC -- $75,487.36 4,472 BPCK358
0.10% SNDX SYNDAX PHARMACEUTICALS INC -- $75,411.00 3,591 BN7Q7R7
0.10% ANAB ANAPTYSBIO INC -- $75,180.11 1,129 BDRW1L7
0.10% PHVS PHARVARIS NV -- $74,875.68 2,608 BMZ2X38
0.10% TRVI TREVI THERAPEUTICS INC -- $74,460.86 5,218 BJH9ZN0
0.10% RXRX RECURSION PHARMACEUTICALS-A -- $73,936.08 21,246 BM9FJ13
0.10% HRMY HARMONY BIOSCIENCES HOLDINGS -- $73,122.75 2,355 BKSGZN7
0.10% ANIP ANI PHARMACEUTICALS INC -- $72,674.80 913 BCDWBX6
0.09% TSHA TAYSHA GENE THERAPIES INC -- $72,016.08 11,148 BNC1BX1
0.09% SION SIONNA THERAPEUTICS INC -- $71,283.78 1,818 BQKXDX4
0.09% INVA INNOVIVA INC -- $70,407.04 3,014 BDDXF67
0.09% GMAB GENMAB A/S -SP ADR -- $69,823.44 2,621 BBC9WC7
0.09% NRIX NURIX THERAPEUTICS INC -- $69,027.14 4,186 BMVLGP2
0.09% RAPP RAPPORT THERAPEUTICS INC -- $68,711.40 1,941 BR3T9B6
0.09% VIR VIR BIOTECHNOLOGY INC -- $68,053.44 6,396 BK4PZ38
0.08% ATAI ATAIBECKLEY INC -- $64,158.22 14,783 BWJDYK1
0.08% NTLA INTELLIA THERAPEUTICS INC -- $62,696.32 4,808 BYZM6C2
0.08% HROW HARROW INC -- $62,570.51 1,511 BHNDW86
0.08% GLUE MONTE ROSA THERAPEUTICS INC -- $59,895.45 3,105 BP7KZP7
0.08% ARDX ARDELYX INC -- $59,786.19 9,981 BN89V40
0.08% MBX MBX BIOSCIENCES INC -- $58,377.22 1,826 BQXJKH2
0.08% AGIO AGIOS PHARMACEUTICALS INC -- $58,241.12 2,384 BCBVTX1
0.08% BCAX BICARA THERAPEUTICS INC -- $57,963.03 2,579 BQB42F1
0.08% NVCR NOVOCURE LTD -- $57,807.36 4,632 BYSS4X4
0.08% IOVA IOVANCE BIOTHERAPEUTICS INC -- $57,514.24 16,768 BF0DMK7
0.07% PGEN PRECIGEN INC -- $57,039.84 14,404 BKM5C84
0.07% CRVS CORVUS PHARMACEUTICALS INC -- $53,523.04 3,362 BYP80F1
0.07% NVAX NOVAVAX INC -- $53,496.03 6,629 BJDQXG4
0.07% WVE WAVE LIFE SCIENCES LTD -- $53,181.22 7,663 BYZG9R0
0.07% MAZE MAZE THERAPEUTICS INC -- $51,828.26 1,958 BSRK699
0.07% ABCL ABCELLERA BIOLOGICS INC -- $51,334.40 12,340 BL53SR3
0.07% AVBP ARRIVENT BIOPHARMA INC -- $51,015.06 1,682 BMGTLY5
0.07% IMCR IMMUNOCORE HOLDINGS PLC-ADR -- $50,951.04 1,784 BLCD809
0.07% OLMA OLEMA PHARMACEUTICALS INC -- $49,860.69 3,261 BMZ4LN0
0.06% GHRS GH RESEARCH PLC -- $49,496.97 2,526 BP6C0S2
0.06% PAHC PHIBRO ANIMAL HEALTH CORP-A -- $47,101.46 839 BL95N25
0.06% EYPT EYEPOINT INC -- $45,818.40 3,369 BMGS7L1
0.06% SEPN SEPTERNA INC -- $45,688.89 1,821 BQNKXX2
0.06% QURE UNIQURE NV -- $45,394.40 2,536 BJFSR88
0.06% URGN UROGEN PHARMA LTD -- $45,258.08 1,904 BZ7PJQ1
0.06% ALVO ALVOTECH SA -- $44,368.50 13,445 BPNTJ34
0.06% SVRA SAVARA INC -- $42,750.60 8,285 BYXGN81
0.06% OMER OMEROS CORP -- $42,510.16 2,884 B4NB858
0.06% COLL COLLEGIUM PHARMACEUTICAL INC -- $42,351.76 1,292 BX7RSN3
0.06% PCRX PACIRA BIOSCIENCES INC -- $42,029.75 1,645 B3X26D8
0.05% ORIC ORIC PHARMACEUTICALS INC -- $41,636.34 4,086 BKVDFF7
0.05% XERS XERIS BIOPHARMA HOLDINGS INC -- $41,334.48 6,754 BLR7H87
0.05% ZBIO ZENAS BIOPHARMA INC -- $41,251.21 2,219 BQB42H3
0.05% GRFS GRIFOLS SA-ADR -- $40,349.19 4,963 B8K7T65
0.05% FTRE FORTREA HOLDINGS INC -- $40,333.00 3,805 BRXYZ57
0.05% AMPH AMPHASTAR PHARMACEUTICALS IN -- $39,965.90 1,846 BNFWZS4
0.05% GERN GERON CORP -- $39,757.05 25,985 2370381
0.05% KALV KALVISTA PHARMACEUTICALS INC -- $39,431.28 2,058 BD06CS0
0.05% XNCR XENCOR INC -- $39,129.70 2,987 BGCYWN8
0.05% JANX JANUX THERAPEUTICS INC -- $37,724.71 2,477 BMFX8Y7
0.05% PHAT PHATHOM PHARMACEUTICALS INC -- $37,157.54 3,206 BJLKVS6
0.05% ANNX ANNEXON INC -- $35,935.10 5,891 BMVV9R5
0.05% SANA SANA BIOTECHNOLOGY INC -- $35,348.18 10,843 BMFJJ97
0.05% TBPH THERAVANCE BIOPHARMA INC -- $34,695.84 2,064 BMNDK09
0.04% CMPS COMPASS PATHWAYS PLC -- $34,137.60 3,840 BMC3HS7
0.04% ABUS ARBUTUS BIOPHARMA CORP -- $33,503.84 7,828 BZ0QMB7
0.04% MNKD MANNKIND CORP -- $32,985.46 12,542 BF081J4
0.04% MESO MESOBLAST LTD- SPON ADR -- $32,637.57 2,129 BQS7491
0.04% KURA KURA ONCOLOGY INC -- $32,125.94 3,542 BYZD465
0.04% SPRY ARS PHARMACEUTICALS INC -- $31,998.75 4,025 BMCR7V2
0.04% BIOA BIOAGE LABS INC -- $31,912.02 1,767 BT9K6D8
0.04% CGEM CULLINAN THERAPEUTICS INC -- $31,879.50 2,406 BM90J52
0.04% ZLAB ZAI LAB LTD-ADR -- $30,522.60 1,395 BD9GVY0
0.04% CSTL CASTLE BIOSCIENCES INC -- $30,225.80 1,210 BKLCWZ3
0.04% MGTX MEIRAGTX HOLDINGS PLC -- $29,909.88 3,276 BFYQFJ2
0.04% ABSI ABSCI CORP -- $29,686.85 6,121 BN94K69
0.04% DSGN DESIGN THERAPEUTICS INC -- $29,680.77 2,317 BMFK3H6
0.04% CTMX CYTOMX THERAPEUTICS INC -- $29,583.84 6,896 BYWVTY5
0.04% PRME PRIME MEDICINE INC -- $26,963.49 7,347 BPBJFM7
0.04% ARVN ARVINAS INC -- $26,795.16 2,604 BDZ30Q0
0.04% IRWD IRONWOOD PHARMACEUTICALS INC -- $26,756.92 6,623 B3MZ6K5
0.03% ETON ETON PHARMACEUTICALS INC -- $25,583.95 1,091 BGL0JK3
0.03% PSNL PERSONALIS INC -- $25,383.64 4,259 BJQ0608
0.03% CRMD CORMEDIX INC -- $25,070.92 3,206 BJ0LT31
0.03% VOR VOR BIOPHARMA INC -- $23,905.16 1,693 BRJJYT3
0.03% SLDB SOLID BIOSCIENCES INC -- $23,805.00 3,174 BQHN6C7
0.03% PRTA PROTHENA CORP PLC -- $23,619.31 2,189 B91XRN2
0.03% RIGL RIGEL PHARMACEUTICALS INC -- $22,607.91 741 BQD3J33
0.03% ZVRA ZEVRA THERAPEUTICS INC -- $22,464.90 2,290 BLFBZ32
0.03% TECX TECTONIC THERAPEUTIC INC -- $21,993.75 765 BPBPCG8
0.03% MRVI MARAVAI LIFESCIENCES HLDGS-A -- $21,925.44 5,958 BMCWKZ2
0.03% ACRS ACLARIS THERAPEUTICS INC -- $21,639.87 4,907 BYV2W40
0.03% FULC FULCRUM THERAPEUTICS INC -- $20,921.20 2,710 BJDX8Z9
0.03% KYTX KYVERNA THERAPEUTICS INC -- $20,901.75 2,325 BSMLR16
0.03% ALLO ALLOGENE THERAPEUTICS INC -- $20,583.00 9,148 BFZNYB7
0.03% TRAX FIRST TRACKS BIOTHERAPEUTICS -- $20,434.90 1,129 BS2CR64
0.03% UPB UPSTREAM BIO INC -- $20,428.71 2,199 BRCFFK6
0.03% AQST AQUESTIVE THERAPEUTICS INC -- $20,352.40 4,964 BYVQJ96
0.03% TRDA ENTRADA THERAPEUTICS INC -- $20,217.60 1,560 BP81RK8
0.03% LRMR LARIMAR THERAPEUTICS INC -- $19,620.36 4,419 BMXNGZ6
0.03% FDMT 4D MOLECULAR THERAPEUTICS IN -- $19,608.75 2,075 BKLXFX5
0.03% LYEL LYELL IMMUNOPHARMA INC -- $19,566.30 865 BTNMG41
0.03% PACB PACIFIC BIOSCIENCES OF CALIF -- $19,544.28 12,292 B4N8MH9
0.03% KMDA KAMADA LTD -- $19,253.60 2,348 B2Q9833
0.02% CADL CANDEL THERAPEUTICS INC -- $18,719.04 2,976 BP0TQC5
0.02% ESPR ESPERION THERAPEUTICS INC -- $18,582.39 9,729 BBNBTD2
0.02% AURA AURA BIOSCIENCES INC -- $17,984.64 2,584 BP81R42
0.02% RGNX REGENXBIO INC -- $17,765.82 2,061 BZ0G875
0.02% GLPG GALAPAGOS NV-SPON ADR -- $17,195.88 604 B292NQ7
0.02% AVIR ATEA PHARMACEUTICALS INC -- $17,034.08 3,178 BLN9Z50
0.02% NGNE NEUROGENE INC -- $17,014.45 629 BS2F741
0.02% LXEO LEXEO THERAPEUTICS INC -- $16,711.88 2,971 BQ6C357
0.02% IVVD INVIVYD INC -- $16,465.88 11,278 BM8NHS1
0.02% VNDA VANDA PHARMACEUTICALS INC -- $16,411.43 2,417 B12W3P6
0.02% CTNM CONTINEUM THERAPEUTICS INC-A -- $16,069.83 1,239 BPRBTY7
0.02% ENTA ENANTA PHARMACEUTICALS INC -- $15,696.96 1,182 B9L5200
0.02% PBYI PUMA BIOTECHNOLOGY INC -- $15,538.19 2,069 B7F2TY6
0.02% RCKT ROCKET PHARMACEUTICALS INC -- $15,425.80 4,420 BDFKQ07
0.02% NMRA NEUMORA THERAPEUTICS INC -- $15,102.66 6,803 BN4JN37
0.02% IMRX IMMUNEERING CORP - CLASS A -- $15,027.84 2,609 BMVBZF5
0.02% SLN SILENCE THERAPEUTICS PLC-ADR -- $14,944.02 1,911 BL5B6Z1
0.02% ALT ALTIMMUNE INC -- $14,268.80 5,096 BFY7DC4
0.02% EOLS EVOLUS INC -- $13,770.36 2,638 BDRJH21
0.02% KROS KEROS THERAPEUTICS INC -- $13,652.40 1,240 BM7V485
0.02% SIGA SIGA TECHNOLOGIES INC -- $13,296.96 2,916 2107437
0.02% LENZ LENZ THERAPEUTICS INC -- $12,424.48 1,273 BQV0J03
0.02% AVXL ANAVEX LIFE SCIENCES CORP -- $12,416.46 3,774 BYTYP72
0.02% FHTX FOGHORN THERAPEUTICS INC -- $12,415.43 2,383 BMF7DT9
0.02% ACIU AC IMMUNE SA -- $11,635.48 4,097 BZC0D70
0.02% AUTL AUTOLUS THERAPEUTICS PLC -- $11,595.72 8,166 BFMLGR4
0.02% EDIT EDITAS MEDICINE INC -- $11,484.86 3,974 BZ8FPH3
0.01% CABA CABALETTA BIO INC -- $11,395.56 3,916 BK5MWR1
0.01% CCCC C4 THERAPEUTICS INC -- $11,240.76 3,972 BKX9NQ0
0.01% CHRS COHERUS ONCOLOGY INC -- $11,194.56 6,084 BRK0149
0.01% NBP NOVABRIDGE BIOSCIENCES -- $11,102.67 4,569 BKRRKY7
0.01% SGMT SAGIMET BIOSCIENCES INC-A -- $10,255.56 1,263 BP2NYN2
0.01% CDXS CODEXIS INC -- $9,741.40 3,676 B5LL2C2
0.01% ARCT ARCTURUS THERAPEUTICS HOLDIN -- $9,603.10 1,157 BKC9SX3
0.01% OBIO ORCHESTRA BIOMED HOLDINGS IN -- $9,421.80 2,298 BPRB2N7
0.01% VYGR VOYAGER THERAPEUTICS INC -- $9,024.00 2,400 BY7RB53
0.01% REPL REPLIMUNE GROUP INC -- $9,010.16 3,362 BDDVW37
0.01% BCYC BICYCLE THERAPEUTICS PLC-ADR -- $8,986.68 1,884 BKDQKM6
0.01% OABI OMNIAB INC -- $8,435.52 5,858 BN13S71
0.01% CRBU CARIBOU BIOSCIENCES INC -- $8,100.39 3,803 BNYJR68
0.01% LFCR LIFECORE BIOMEDICAL INC -- $7,736.84 1,523 2517058
0.01% QSI QUANTUM-SI INC -- $7,160.99 7,954 BNR5QT9
0.01% TKNO ALPHA TEKNOVA INC -- $6,842.06 2,179 BP7L561
0.01% BDTX BLACK DIAMOND THERAPEUTICS I -- $6,768.56 2,318 BKTV702
0.01% MENS JYONG BIOTECH LTD -- $6,493.00 3,020 BPTK6Z2
0.01% HUMA HUMACYTE INC -- $6,331.96 7,857 BMYTJP4
0.01% TNYA TENAYA THERAPEUTICS INC -- $6,176.10 8,823 BNNXX52
0.01% AARD AARDVARK THERAPEUTICS INC -- $4,890.72 886 BTXQTX3
0.01% PEPG PEPGEN INC -- $4,480.00 2,800 BMTX3D7
0.01% PYXS PYXIS ONCOLOGY INC -- $4,461.60 2,535 BLBR8D5
-- RANI RANI THERAPEUTICS HOLDINGS-A -- $3,533.79 3,971 BNNXX18
-- GOSS GOSSAMER BIO INC -- $3,282.52 9,419 BJ0CK86
-- THRD THIRD HARMONIC BIO INC -- $00.00 1,662 BNNPQY8
-- 2324462D CARTESIAN THERAPEUTICS-CVR -- $00.00 9,785 BM9HFX3
35.99% -- NASDAQ BIO INDEX SWAP BNP PARIBAS 27,419,870 -- 4,669 --
28.53% -- NASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NA 21,740,921 -- 3,702 --
27.16% -- NASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NA 20,695,571 -- 3,524 --
20.34% -- NASDAQ BIOTECHNOLOGY INDEX SWAP GOLDMAN SACHS INTERNATIONAL 15,498,187 -- 2,639 --
16.97% -- NASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALE 12,925,923 -- 2,201 --
4.88% -- NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AG 3,717,451 -- 633 --
-- -- NET OTHER ASSETS (LIABILITIES) -- $25,640,826.29 25,640,826 --

Index

as of 3/31/2026

  • Total Number of Companies256
  • Price/Book Ratio3.78
  • Dividend Yield ( % )0.85
  • Avg. Index Market Capitalization$6.50 billion
About the Index

The Nasdaq Biotechnology Index is designed to measure the performance of a set of Nasdaq-listed biotechnology and pharmaceutical companies.

Distributions

Ex-Dividend Date Record Date Payable Date Dividend Long-Term Capital Gain Short-Term Capital Gain Return of Capital
Get the latest perspectives and updates.

For the total return table above, since inception returns are cumulative for funds less than one year old; otherwise, returns are annualized. Market returns are based on the composite closing price and do not represent the returns you would receive if you traded shares at other times. The listing date is typically one or more days after the fund inception date. Therefore, NAV is used to calculate market returns prior to the listing date.

The expense ratio for certain funds includes a contractual fee waiver that results in a lower net expense ratio for some or all periods shown. For information about this ETF’s fees, please see above.

Holdings are subject to change. ProShares may invest in financial instruments (including derivatives) that, in combination, should have daily price return characteristics similar to the fund's benchmark.

Registered Investment Companies are required by the IRS to distribute substantially all of their income and capital gains to shareholders at least annually. For specific tax advice, we recommend you speak with a qualified tax professional.

This ProShares ETF seeks daily investment results that correspond, before fees and expenses, to 2x the daily performance of its underlying benchmark (the “Daily Target”). While the Fund has a daily investment objective, you may hold Fund shares for longer than one day if you believe it is consistent with your goals and risk tolerance. For any holding period other than a day, your return may be higher or lower than the Daily Target. These differences may be significant. Smaller index gains/losses and higher index volatility contribute to returns worse than the Daily Target. Larger index gains/losses and lower index volatility contribute to returns better than the Daily Target. The more extreme these factors are, the more they occur together, and the longer your holding period while these factors apply, the more your return will tend to deviate. Investors should consider periodically monitoring their geared fund investments in light of their goals and risk tolerance.

Index information does not reflect any management fees, transaction costs or expenses. Indexes are unmanaged, and one cannot invest directly in an index.

The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than the original cost. Shares are bought and sold at market price (not NAV) and are not individually redeemed from the fund. Market price returns are based upon the midpoint of the bid/ask spread at 4:00 p.m. ET (when NAV is normally determined for most funds) and do not represent the returns you would receive if you traded shares at other times. Your brokerage commissions will reduce returns. Current performance may be lower or higher than the performance quoted. For standardized returns and performance data current to the most recent month end, see above.

There is no guarantee that capital gain distributions will not be made in the future. There is no guarantee that dividends or interest income will be paid.

There is no guarantee any ProShares ETF will achieve its investment objective.

Shares of any ETF are generally bought and sold at market price (not NAV) and are not individually redeemed from the fund. Your brokerage commissions will reduce returns.

Investing involves risk, including the possible loss of principal. Leveraged ProShares ETFs are non-diversified and entail certain risks, including risk associated with the use of derivatives (swap agreements, futures contracts and similar instruments), imperfect benchmark correlation, leverage and market price variance, all of which can increase volatility and decrease performance. Please see their summary and full prospectuses for a more complete description of risks.

Technology companies may be subject to intense competition, product obsolescence, general economic conditions and government regulation and may have limited product lines, markets, financial resources or personnel.

The fund concentrates its investments in certain sectors. Narrowly focused investments typically exhibit higher volatility.

Carefully consider the investment objectives, risks, charges and expenses of ProShares before investing. This and other information can be found in their summary and full prospectuses. Read them carefully before investing.

The "Nasdaq Biotechnology Index®" is a trademark of The Nasdaq OMX Group, Inc. ("Nasdaq OMX") and has been licensed for use by ProShares. ProShares have not been passed on by Nasdaq OMX or its subsidiaries or affiliates as to their legality or suitability. ProShares based on the Nasdaq Biotechnology Index are not sponsored, endorsed, sold or promoted by Nasdaq OMX or its subsidiaries or affiliates, and they make no representation regarding the advisability of investing in ProShares. THIS ENTITY AND ITS AFFILIATES MAKE NO WARRANTIES AND BEAR NO LIABILITY WITH RESPECT TO PROSHARES.

Quote data provided by Interactive Data - Real Time Services, Inc. and subject to terms of use.

ProShares are distributed by SEI Investments Distribution Co., which is not affiliated with the funds’ advisor or sponsor.

Your use of this site signifies that you accept our Terms and Conditions of Use.